ipilimumab
bms
['congrat', 'melanoma']
#esmo22 historical moment for us in melanoma: til therapy made it in phase iii academic trial conducted at nki netherlands under the coordination of john haanen! (foto 2 by martina rooijakkers) and melanoma patients acknowledged! congratulations! 
Ph.D biologist and #Melanoma Patient Advocate